Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1673-2025

Stratus CS Acute Care cTNI TestPak.IVD test for cardiac troponin I in heparinized plasma. Recall

Stratus CS Acute Care cTNI TestPak.IVD test for cardiac troponin I in heparinized plasma.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Stratus CS Acute Care cTNI TestPak.IVD test for cardiac troponin I in heparinized plasma.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1673-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Mar 31, 2025
FDA report date
May 7, 2025
Quantity in commerce
367 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Stratus CS Acute Care cTNI TestPak.IVD test for cardiac troponin I in heparinized plasma.

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

Siemens Materials No. 10445071; UDI-DI: 0405686902174VK; Lot No. 234337002 and forward.

View the original FDA recall notice

Why was this product recalled?

Siemens Healthcare Diagnostics Inc., is recalling their Stratus CS Acute Care cTNI TestPak, an IVD test for cardiac troponin I in heparinized plasma by removal. The reason for the recall is an increased occurrence of random non-repeatable false positive cardiac Troponin l(cTnI) results at any point during the TestPaks shelf life when using the Stratus CS cTnI Acute Care Testpak.

What actions did Siemens Healthcare Diagnostics, Inc. take?

An Urgent Medical Device Correction notice dated March 2025 was mailed to consignees. The notice instructed consignees to review the provided notification with their medical director to determine the appropriate course of action. Siemens will reimburse users for repeat tests and discarded units associated with this recall; consignees should contact the Customer Care Center for reimbursement. If product was further distributed, Siemens asks that the recall notification be forwarded. The recall notification is to be retained with laboratory records and forwarded to those who use the recalled devices. Consignees with any questions can contact Siemens Healthineers Technical Solutions Center at 977-229-3711.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology